{"id":"https://openalex.org/W2744595682","doi":"https://doi.org/10.25004/ijpsdr.2016.080406","title":"FORMULATION AND DEVELOPMENT OF STABLE METAXALONE NANOSUSPENSION USING 32 FACTORIAL DESIGN","display_name":"FORMULATION AND DEVELOPMENT OF STABLE METAXALONE NANOSUSPENSION USING 32 FACTORIAL DESIGN","publication_year":2016,"publication_date":"2016-07-01","ids":{"openalex":"https://openalex.org/W2744595682","doi":"https://doi.org/10.25004/ijpsdr.2016.080406","mag":"2744595682"},"language":"en","primary_location":{"id":"doi:10.25004/ijpsdr.2016.080406","doi":"https://doi.org/10.25004/ijpsdr.2016.080406","is_oa":true,"landing_page_url":"https://doi.org/10.25004/ijpsdr.2016.080406","pdf_url":"http://ijpsdr.com/index.php/ijpsdr/article/download/544/497","source":{"id":"https://openalex.org/S2764983607","display_name":"International Journal of Pharmaceutical Sciences and Drug Research","issn_l":"0975-248X","issn":["0975-248X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Sciences and Drug Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://ijpsdr.com/index.php/ijpsdr/article/download/544/497","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083380115","display_name":"Paras R. Vasanani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paras R. Vasanani","raw_affiliation_strings":["D-404, Silver Pearl Apartment, Chankyapuri road, Ghatlodia, Ahmedabad-380061, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D-404, Silver Pearl Apartment, Chankyapuri road, Ghatlodia, Ahmedabad-380061, Gujarat, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011104597","display_name":"L. D. Patel","orcid":"https://orcid.org/0000-0003-1511-2315","observed_orcids":["https://orcid.org/0000-0003-1511-2315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. D. Patel","raw_affiliation_strings":["Sharda School of Pharmacy, Gandhinagar-382610, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharda School of Pharmacy, Gandhinagar-382610, Gujarat, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002314753","display_name":"Chetan M. Detroja","orcid":"https://orcid.org/0000-0001-7855-2671","observed_orcids":["https://orcid.org/0000-0001-7855-2671"]},"institutions":[{"id":"https://openalex.org/I137674396","display_name":"RK University","ror":"https://ror.org/057ap5t09","country_code":"IN","type":"education","lineage":["https://openalex.org/I137674396"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chetan M. Detroja","raw_affiliation_strings":["R. K. University, Bhavnagar Highway, Kasturbadham, Rajkot-360020, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R. K. University, Bhavnagar Highway, Kasturbadham, Rajkot-360020, Gujarat, India","institution_ids":["https://openalex.org/I137674396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"223","last_page":"228"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metaxalone","display_name":"metaxalone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nanoparticle-suspensions","display_name":"nanoparticle suspensions","score":0.996999979019165},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.921999990940094},{"id":"https://openalex.org/keywords/bcs-class-ii","display_name":"BCS class II","score":0.8820000290870667},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.777999997138977},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/media-milling","display_name":"media milling","score":0.7889999747276306},{"id":"https://openalex.org/keywords/pluronic-f127","display_name":"Pluronic F127","score":0.972000002861023},{"id":"https://openalex.org/keywords/surfactant-concentration","display_name":"surfactant concentration","score":0.9290000200271606},{"id":"https://openalex.org/keywords/stirring-time","display_name":"stirring time","score":0.9229999780654907},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.972000002861023},{"id":"https://openalex.org/keywords/saturation-solubility","display_name":"saturation solubility","score":0.9660000205039978},{"id":"https://openalex.org/keywords/dissolution","display_name":"dissolution","score":0.4230000078678131},{"id":"https://openalex.org/keywords/muscle-relaxants","display_name":"muscle relaxants","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.9091274738311768},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.789979100227356},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.7611704468727112},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6886635422706604},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.683207094669342},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.6729629039764404},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.6394379734992981},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.56298828125},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5016579627990723},{"id":"https://openalex.org/C9930424","wikidata":"https://www.wikidata.org/wiki/Q7426587","display_name":"Saturation (graph theory)","level":2,"score":0.4447484612464905},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3981820344924927},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.3567703068256378},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.23302388191223145},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.13994988799095154},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13929182291030884},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13893157243728638},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.06952741742134094},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06138002872467041},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C114614502","wikidata":"https://www.wikidata.org/wiki/Q76592","display_name":"Combinatorics","level":1,"score":0.0},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25004/ijpsdr.2016.080406","doi":"https://doi.org/10.25004/ijpsdr.2016.080406","is_oa":true,"landing_page_url":"https://doi.org/10.25004/ijpsdr.2016.080406","pdf_url":"http://ijpsdr.com/index.php/ijpsdr/article/download/544/497","source":{"id":"https://openalex.org/S2764983607","display_name":"International Journal of Pharmaceutical Sciences and Drug Research","issn_l":"0975-248X","issn":["0975-248X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Sciences and Drug Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25004/ijpsdr.2016.080406","doi":"https://doi.org/10.25004/ijpsdr.2016.080406","is_oa":true,"landing_page_url":"https://doi.org/10.25004/ijpsdr.2016.080406","pdf_url":"http://ijpsdr.com/index.php/ijpsdr/article/download/544/497","source":{"id":"https://openalex.org/S2764983607","display_name":"International Journal of Pharmaceutical Sciences and Drug Research","issn_l":"0975-248X","issn":["0975-248X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Sciences and Drug Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2744595682.pdf","grobid_xml":"https://content.openalex.org/works/W2744595682.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1990594310","https://openalex.org/W2003093213","https://openalex.org/W2056211275","https://openalex.org/W2185333405","https://openalex.org/W2482482479"],"related_works":["https://openalex.org/W2746431934","https://openalex.org/W7220646279","https://openalex.org/W4402325217","https://openalex.org/W6893101067","https://openalex.org/W4405507540","https://openalex.org/W2103037903","https://openalex.org/W7162195415","https://openalex.org/W3031291235","https://openalex.org/W7215374139","https://openalex.org/W7127923333"],"abstract_inverted_index":{"Nanosuspensions":[0],"are":[1],"the":[2,35,121,210,266],"dispersions":[3],"of":[4,29,86,95,108,124,165,173,192,249,261],"nanosized":[5],"particles":[6],"in":[7,18,45,104,224,227],"a":[8],"suitable":[9],"vehicle":[10],"prepared":[11],"using":[12,145,187,209],"surfactants":[13],"or":[14,49],"solubilizers":[15],"to":[16,34,116,149,229,246,256],"aid":[17],"nanosize":[19],"distribution.":[20],"Nanosuspension":[21],"is":[22,75],"best":[23],"suited":[24],"for":[25,93,132],"dosage":[26],"form":[27],"development":[28],"poorly":[30],"soluble":[31],"drugs.":[32],"According":[33],"biopharmaceutical":[36],"classification":[37],"system,":[38],"drugs":[39,56],"with":[40,98],"poor":[41,58],"solubility":[42,59,118,156,171,206,248],"fall":[43],"either":[44],"BCS":[46,50,53,78,251],"class":[47,51,54,79,85,252],"II":[48,55,80,253],"IV.":[52],"show":[57],"and":[60,119,139,154,168,195,198,204,213,255,259],"good":[61],"permeability;":[62],"hence":[63,120],"their":[64,72,199],"bioavailability":[65,123],"problems":[66],"can":[67],"be":[68,243],"overcome":[69],"by":[70],"improving":[71],"solubility.":[73],"Metaxalone":[74,109],"one":[76],"such":[77],"drug":[81,254],"from":[82,180,233],"an":[83,114],"oxazolidin-2-one":[84],"centrally":[87],"acting":[88],"muscle":[89],"relaxant":[90],"drugs,":[91],"indicated":[92],"relief":[94],"discomforts":[96],"associated":[97],"acute,":[99],"painful":[100],"musculoskeletal":[101],"conditions.":[102],"Therefore,":[103],"present":[105],"investigation,":[106],"nanosuspension":[107,133],"has":[110,129,142],"been":[111,130,143],"formulated":[112],"as":[113,158,177],"attempt":[115],"improve":[117,247],"overall":[122],"Metaxalone.":[125],"Media":[126],"milling":[127],"technique":[128],"employed":[131,244],"preparation.":[134],"Surfactant":[135],"concentration":[136,194],"(Poloxamer":[137],"407)":[138],"stirring":[140,196],"time":[141,197],"optimized":[144,218],"32":[146],"factorial":[147,181],"design":[148,182],"achieve":[150],"desired":[151],"particle":[152,162,202],"size":[153,163,203],"saturation":[155,170,205],"responses":[157],"dependent":[159],"variables.":[160],"The":[161,217],"(PS)":[164],"215.3":[166],"nm":[167],"maximum":[169],"(SS)":[172],"2805\u03bcg/ml":[174],"was":[175,184,207],"obtained":[176],"suggested":[178],"solutions":[179],"which":[183],"further":[185],"confirmed":[186],"check":[188],"point":[189],"analysis.":[190],"Interaction":[191],"surfactant":[193],"effect":[200],"on":[201],"predicted":[208],"contour":[211],"plots":[212],"response":[214],"surface":[215],"plots.":[216],"formulation":[219],"showed":[220],"around":[221,230],"99%":[222],"metaxalone":[223],"vitro":[225],"dissolution":[226,232],"comparison":[228],"46%":[231],"SKELAXIN\u00ae":[234],"tablet":[235],"at":[236,265],"30":[237],"minutes.":[238],"These":[239],"methodologies":[240],"could":[241],"therefore":[242],"successfully":[245],"any":[250],"predict":[257],"effects":[258],"interactions":[260],"many":[262],"experimental":[263],"variables":[264],"same":[267],"time.":[268]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-08-17T00:00:00"}